European Psychiatry - Volume 41 - April 2017

487 / 916

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S465–S520 S483
Introduction Although psychoactive substance use disorders
(PSUD) belong to the domain of mental health, their management
varies greatly among European countries. Furthermore, both the
role of psychiatrists and trainees in the treatment of PSUD is not
the same for each European country.
Aims Among the context of the European Federation of Psychi-
atric Trainees (EFPT), the PSUD Working Group has developed a
survey that has been spread out between the 15th of august 2015
and 15th of October 2016, at the aimof gathering information about
the training in PSUD in Europe, both fromChild and Adolescent, and
General Adult Psychiatric (CAP and GAP) trainees.
Objectives The survey investigated, at European level, the organi-
sation of the PSUD training, trainees satisfaction, attitudes towards
people who use psychoactive substances, management of pharma-
cologic and involvement in common clinical situations.
Methods A 70-items questionnaire regarding the aforemen-
tioned objectives was developed, and shared trough an online
data-collecting system among European CAP and GAP trainees,
with 40 trainees per country filling the survey in at least 25
countries. One national coordinator per country facilitated the
delivering of the survey.
Results A total of 1250 surveys were filled from more than 25
European countries.
Conclusions Data from the survey will be promptly analysed.
The survey will be the first to explore European psychiatric trainees
attitudes and practices about PSUD. Findings fromthis independent
surveymay serve in understanding the needs of trainees in the field
of substance misuse psychiatry.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV0241
Hepatic comorbidity in psychiatry.
A case report
G. Pardo de Santayana ∗ andera Juncal Porta
L. Sánchez Gómez Nú˜nez
1 Hospital universitario Marques De Valdecilla, psychiatry,
Santander, Spain
2 Hospital universitario Alava-sede Santiago- Vitoria-gasteiz,
psychiatry, Vitoria, Spain
∗ Corresponding author.
Introduction Comorbidity between mental and physical illnesses
is very common and their possible interactions must always be
taken into account. Hepatic disorders in particular, can affect the
blood levels of antipsychotic drugs altering their effects on patients.
Therefore, it is very important to assess in each case which treat-
mentmight be themost beneficial for the patient to avoid iatrogenic
complications.
Aim To review articles in Pub-Med and UpToDate about the pos-
sible iatrogenic complications that can arise using antipsychotic
drugs in patients with hepatic disorders.
Methods We describe the case of a 52-year-old male with
Schizophrenia who was diagnosed of HCV infection ten years
ago, for which he rejected any kind of treatment due to deliri-
ous ideation. In the past he was treated with oral Paliperidone
with good tolerance, which he discontinued because of pour
insight and stopped attending Psychiatric consultation. In April
2016 the patient was hospitalised suspecting a hepatocellular
carcinoma.
Results During hospitalization he began treatment with long-
acting injectable formulation of Paliperidone Palmitate that
improved his insight. The patient agreed to perform the necessary
tests to verify the suspected diagnosis, which was sadly confirmed.
He achieved psychopathological stability, but unfortunately the
patient died 6 months later because of his hepatocellular carci-
noma.
Conclusions Paliperidone is a good therapeutic option in patients
with hepatic disorders because it is not metabolised by the liver. It
also has a depot formulation that improves adherence in patients
with low insight, reducing the danger of future psychotic decom-
pensation and improving the long-term prognosis.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV0242
Cases where pituitary tumor is
presented first with psychiatric signs
are very rare
Dr. Taulant Pengili∗, . Anila Hashorva , Dr. Ina Prifti ,
Dr. Marsida Lici , Dr. Enida Balani
University Hospital Center Mother Theresa, Psychiatry, Tirana,
Albania
∗ Corresponding author.
Objective To describe a rare case of Acromegaly presenting as
psychotic disorder without neurological signs, in a 19 years old boy.
Method Single case report.
Results We describe the case of a 19 years old boy, that was taller
than his peers and had started to grow his hands. He suddenly
presented with an acute psychotic episode. He presented with per-
secutory delusions, perceptual abnormalities, disorganization and
marked fluctuation in his behavior, he showed marked emotional
liability, fluctuations in orientation and psychotic symptoms in the
form of grandiosity, persecutory delusions and delusional misiden-
tifications. At times, he was seen talking to himself, although he
denied hearing any voices. There was no impairment of conscious-
ness. His mood was irritable. An urgent CT and subsequent MRI
scan revealed a pituitary macro adenoma, extending into the cav-
ernous sinus. The initial diagnosis of prolactinoma was revised to
acromegaly. His symptoms responded to combination of olanzap-
ine and valproic acid, followed by trans sphenoid resection of the
adenoma.
Conclusions This case highlights the need for investigation, espe-
cially of neuroimaging, in atypical presentations of psychosis,
which may be first manifestation of rare disorders like acromegaly.
Despite a lack of information regarding the path physiology, this
particular case emphasizes the importance of ruling out an organic
cause for atypical presentation of psychosis.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EV0243
Comorbidity between
obsessive-compulsive disorder and
attention deficit/hyperactivity
disorder
J. Perestrelo ∗, A. Samico , G. Lapa
Centro hospitalar Vila Nova Gaia/Espinho, psychiatry and mental
health, Porto, Portugal
∗ Corresponding author.
Introduction The comorbidity between obsessive-compulsive
disorder (OCD) and attention deficit/hyperactivity disorder (ADHD)
has been discussed for a couple of decades. Reported co-occurrence
rates are highly inconsistent in the literature.
Objective To review phenomenological and theoretical issues
concerning concomitant OCD-ADHD.
Aims Phenomenological and theoretical issues regarding OCD-
ADHD comorbidity are reviewed.
Results Although numerous studies suggest an OCD-ADHD
comorbidity, thus far etiological (i.e., genetic) background has